Understanding how specific proteins help transport modified mRNAs out of the nucleus
METTL3-NUP93 interaction facilitates the nuclear export of m6A-modified mRNAs
['FUNDING_R01'] · UNIVERSITY OF VIRGINIA · NIH-11301965
This study is looking at how two proteins, METTL3 and NUP93, work together to help move important genetic messages out of the cell's nucleus, which could help us understand how genes are controlled and how this might relate to different diseases.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF VIRGINIA (nih funded) |
| Locations | 1 site (CHARLOTTESVILLE, UNITED STATES) |
| Trial ID | NIH-11301965 on ClinicalTrials.gov |
What this research studies
This research investigates the interaction between two proteins, METTL3 and NUP93, which play a crucial role in the export of messenger RNAs (mRNAs) from the nucleus to the cytoplasm. By focusing on a specific modification of mRNAs known as m6A, the study aims to uncover how this modification enhances the transport process. The researchers will analyze how METTL3 binds to NUP93 and facilitates the movement of m6A-modified mRNAs through the nuclear pore complex, which is essential for proper gene expression. This work could lead to a better understanding of gene regulation and its implications for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions related to gene expression abnormalities or mRNA transport issues.
Not a fit: Patients with conditions unrelated to mRNA transport or gene expression regulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve our understanding of gene expression regulation, potentially leading to new therapeutic strategies for diseases linked to mRNA transport dysfunction.
How similar studies have performed: While the specific interaction being studied is novel, previous research has shown that understanding mRNA transport mechanisms can lead to significant advancements in treating related diseases.
Where this research is happening
CHARLOTTESVILLE, UNITED STATES
- UNIVERSITY OF VIRGINIA — CHARLOTTESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: XU, KEXIN — UNIVERSITY OF VIRGINIA
- Study coordinator: XU, KEXIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.